UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060581
Receipt number R000065121
Scientific Title Randomized trial of weaning food for prevention of peanut and nut allergy
Date of disclosure of the study information 2026/02/04
Last modified on 2026/02/04 15:05:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized trial of weaning food for prevention of peanut and nut allergy

Acronym

Randomized trial for prevention of peanut and nut allergy

Scientific Title

Randomized trial of weaning food for prevention of peanut and nut allergy

Scientific Title:Acronym

Randomized trial for prevention of peanut and nut allergy

Region

Japan


Condition

Condition

Food allergy

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify whether early consumption of peanut, walnut, and cashew with weaning food can prevent development of these allergies.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sensitization to peanut, walnut, and cashew at the age of two

Key secondary outcomes

Percentage of patients with allergic symptoms to peanuts, walnuts, or cashews at age two
Percentage of patients with allergic symptoms to foods other than peanuts, walnuts, and cashews at age two
Percentage of patients with sensitization to peanuts, walnuts, cashews, Ara h 2, Jug r 1, Ana o 3, respectively, up to two years of age
Specific IgE level for peanuts, walnuts, cashews, Ara h 2, Jug r 1, Ana o 3, at 1 year 6 months and 2 years
Specific IgG and IgG4 level for peanuts, walnuts, and cashews at 1 year 6 months and 2 years
The results of peanut, walnut, and cashew oral food challenge test in sensitized children
Safety and adverse events related to the trial weaning food
Frequency of trial weaning food intake


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Consume weaning food with peanuts, walnuts, and cashews at least twice a week from 1 year to 1 year and 6 months

Interventions/Control_2

Consume placebo weaning food at least twice a week from 1 year to 1 year and 6 months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 months-old <=

Age-upper limit

12 months-old >

Gender

Male and Female

Key inclusion criteria

Infants under 1 year of age at the time of study enrollment who have sensitization to one or more food allergens by blood test between 6 to 11 months of age.

Key exclusion criteria

Severe atopic dermatitis
Infants with a history of immediate symptoms to peanuts, walnuts, or cashews
Infants with sensitization to peanuts, walnuts, cashews, Ara h 2, Jug r 1, or Ana o 3 by blood test
Infants with concomitant immune disorders
Infants with a history or complications of cardiac, liver, kidney, or blood disease
Infants using systemic steroids regularly
Infants using systemic biologics
Decision of ineligibility by a physician

Target sample size

136


Research contact person

Name of lead principal investigator

1st name Noriyuki
Middle name
Last name Yanagida

Organization

National Hospital Organization Sagamihara National Hospital

Division name

Pediatrics

Zip code

252-0392

Address

18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan, 252-0392

TEL

042-742-8311

Email

yana@foodallergy.jp


Public contact

Name of contact person

1st name Noriyuki
Middle name
Last name Yanagida

Organization

National Hospital Organization Sagamihara National Hospital

Division name

Pediatrics

Zip code

252-0392

Address

18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan, 252-0392

TEL

042-742-8311

Homepage URL


Email

yana@foodallergy.jp


Sponsor or person

Institute

National Hospital Organization Sagamihara National Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development (AMED)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Miyagi Children's Hospital
Aichi Children's Health and Medical Center
Showa Medical University Hospital
National Hospital Organization Mie National Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Sagamihara National Hospital

Address

18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan, 252-0392

Tel

042-742-8311

Email

makino.megumi.bn@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 12 Month 01 Day

Date of IRB

2024 Year 11 Month 08 Day

Anticipated trial start date

2024 Year 12 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 02 Month 04 Day

Last modified on

2026 Year 02 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065121